MOH — authorised 5 May 1987
- Marketing authorisation holder: ABRAXIS PHARM
- Status: likely_approved
MOH authorised Zinc Sulfate on 5 May 1987
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 5 May 1987.
ABRAXIS PHARM holds the UAE marketing authorisation.